2140264-64-6
Chemical Structure
Clindamycin Hydrochloride-13C,d3
- CAS No.: 2140264-64-6
- Formula:C1713CH31D3Cl2N2O5S
- Molecular Weight:465.46
IUPAC Name: (2S,4R)-N-((1S,2S)-2-chloro-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-(methyl-13C-d3)-4-propylpyrrolidine-2-carboxamide hydrochloride
InChIKey: AUODDLQVRAJAJM-QBUBXJGKSA-N
SMILES: CCC[C@@H]1C[C@H](N(C1)[13C]([2H])([2H])[2H])C(N[C@H]([C@H](C)Cl)[C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)=O.Cl
Biological Activity: Clindamycin Hydrochloride-13C,d3 is the deuterium and 13C-labeled Clindamycin hydrochloride (HY-B0408A). Clindamycin hydrochloride is a semisynthetic lincosamide antibiotic, which inhibits protein synthesis by acting on the 50S ribosomal.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Clindamycin Hydrochloride-13C,d3 | Clindamycin Hydrochloride-13C,d3 is the deuterium and 13C-labeled Clindamycin hydrochloride (HY-B0408A). Clindamycin hydrochloride is a semisynthetic lincosamide antibiotic, which inhibits protein synthesis by acting on the 50S ribosomal. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Clindamycin hydrochloride (Standard) | 99.46% | Clindamycin (hydrochloride) (Standard) is the analytical standard of Clindamycin (hydrochloride). This product is intended for research and analytical applications. Clindamycin (hydrochloride) is a semisynthetic lincosamide antibiotic, which inhibits protein synthesis by acting on the 50S ribosomal. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Clindamycin-d3 hydrochloride | Clindamycin-d3 (hydrochloride) is the deuterium labeled Clindamycin. Clindamycin is an orally active and broad-spectrum bacteriostatic lincosamide antibiotic. Clindamycin can inhibit bacterial protein synthesis, possessing the ability to suppress the expression of virulence factors in Staphylococcus aureus at sub-inhibitory concentrations (sub-MICs). Clindamycin resistance results from enzymatic methylation of the antibiotic binding site in the 50S ribosomal subunit (23S rRNA). Clindamycin decreases the production of Panton-Valentine leucocidin (PVL), toxic-shock-staphylococcal toxin (TSST-1) or alpha-haemolysin (Hla). Clindamycin also can be used for researching malaria. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Clindamycin hydrochloride | 99.91% | Clindamycin (hydrochloride) is a semisynthetic lincosamide antibiotic, which inhibits protein synthesis by acting on the 50S ribosomal. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
